We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
-0.3%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$752M
AUM Growth
+$253M
Cap. Flow
+$268M
Cap. Flow %
35.64%
Top 10 Hldgs %
9.6%
Holding
1,082
New
405
Increased
619
Reduced
41
Closed
17

Top Buys

Rank Stock Value
1
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
+$17.4M
2
AAPL icon
Apple
AAPL
+$7.52M
3
AVGO icon
Broadcom
AVGO
+$6.81M
4
BHC icon
Bausch Health
BHC
+$5.93M
5
NBIS
Nebius Group N.V.
NBIS
+$4.82M

Top Sells

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$2.86M
2
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
+$1.98M
3
EGLE
Eagle Bulk Shipping Inc.
EGLE
+$1.84M
4
ALTR
Altera Corp
ALTR
+$1.74M
5
PCYC
PHARMACYCLICS INC
PCYC
+$1.64M

Sector Composition

Rank Sector Weight
1 Technology 15.2%
2 Healthcare 13.08%
3 Industrials 11.83%
4 Financials 9.36%
5 Consumer Discretionary 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCHP icon
176
Microchip Technology
MCHP
$40.4B
$1.17M 0.16%
+49,384
New +$1.2M
FLEX icon
177
Flex
FLEX
$45.3B
$1.17M 0.16%
137,130
+7,028
+5% +$64.7K
LHX icon
178
L3Harris
LHX
$53.9B
$1.16M 0.15%
15,138
+4,146
+38% +$329K
AVTA
179
DELISTED
Avantax, Inc. Common Stock
AVTA
$1.16M 0.15%
71,995
+3,206
+5% +$49.4K
NSR
180
DELISTED
Neustar Inc
NSR
$1.16M 0.15%
39,645
+1,764
+5% +$49.9K
JAZZ icon
181
Jazz Pharmaceuticals
JAZZ
$16.7B
$1.15M 0.15%
+6,529
New +$1.17M
RSG icon
182
Republic Services
RSG
$64.5B
$1.15M 0.15%
29,332
+2,137
+8% +$86K
RLD
183
DELISTED
REALD INC COM STK
RLD
$1.14M 0.15%
92,737
+4,113
+5% +$51.5K
TRMB icon
184
Trimble
TRMB
$13.6B
$1.14M 0.15%
+48,672
New +$1.19M
WU icon
185
Western Union
WU
$2.23B
$1.14M 0.15%
56,161
+3,840
+7% +$81.7K
LLY icon
186
Eli Lilly
LLY
$1.06T
$1.13M 0.15%
13,579
+1,014
+8% +$77.3K
LHCG
187
DELISTED
LHC Group LLC
LHCG
$1.13M 0.15%
29,615
+1,563
+6% +$55.2K
DO
188
DELISTED
Diamond Offshore Drilling
DO
$1.13M 0.15%
43,901
+4,035
+10% +$123K
IPGP icon
189
IPG Photonics
IPGP
$3.69B
$1.13M 0.15%
+13,272
New +$1.25M
TGT icon
190
Target
TGT
$66.8B
$1.13M 0.15%
13,842
+878
+7% +$71.1K
AVP
191
DELISTED
Avon Products, Inc.
AVP
$1.12M 0.15%
179,424
+14,996
+9% +$111K
CHE icon
192
Chemed
CHE
$7.18B
$1.12M 0.15%
8,557
+383
+5% +$47.4K
CVG
193
DELISTED
Convergys
CVG
$1.09M 0.15%
42,953
+1,931
+5% +$46.8K
JPC icon
194
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
$1.08M 0.14%
+118,129
New +$1.13M
MGLN
195
DELISTED
Magellan Health Services, Inc.
MGLN
$1.07M 0.14%
15,273
+684
+5% +$46.5K
PRKS icon
196
United Parks & Resorts
PRKS
$2.09B
$1.07M 0.14%
57,954
+2,573
+5% +$53.3K
LDOS icon
197
Leidos
LDOS
$17B
$1.06M 0.14%
26,331
+1,179
+5% +$49.6K
ESRX
198
DELISTED
Express Scripts Holding Company
ESRX
$1.04M 0.14%
11,702
+867
+8% +$75.7K
ANGO icon
199
AngioDynamics
ANGO
$625M
$1.04M 0.14%
63,372
+2,881
+5% +$47.8K
CBM
200
DELISTED
Cambrex Corporation
CBM
$1.03M 0.14%
23,557
+1,346
+6% +$55.7K
6 7
8
9 10

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q2 2015 Portfolio in Review

As of Q2 2015, Vident Investment Advisory held 1,082 positions worth $752M, up 51% from $498M the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Vident Investment Advisory deployed $268M of net new capital in Q2 2015, opening 405 new positions and adding to 619 existing holdings. Its largest new stake was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $2.86M trimmed.

  • Vident Investment Advisory's largest Q2 2015 buy was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.
  • Vident Investment Advisory added most to Apple in Q2 2015, an estimated $7.52M increase.
  • Vident Investment Advisory's biggest Q2 2015 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $2.86M.
  • Vident Investment Advisory fully exited AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2015, selling an estimated $1.98M.
  • Vident Investment Advisory's ten largest holdings make up 9.6% of its $752M portfolio in Q2 2015.
  • Vident Investment Advisory opened 405 new positions and closed 17 in Q2 2015.
  • Vident Investment Advisory's portfolio value rose 51% quarter-over-quarter to $752M.

Based on Vident Investment Advisory's 13F filing for Q2 2015, filed 29 Jul 2015.